PROS2P: A Potential Drug Target for Various Diseases (G5628)

Target Name: PROS2P

NCBI ID: G5628

PROS2P

Other Name(s): protein S (beta) pseudogene | Protein S (beta) pseudogene | PROS2 | PROSP

PROS2P: A Potential Drug Target for Various Diseases

PROS2P, also known as protein S (beta) pseudogene, is a gene that has been identified as a potential drug target or biomarker for various diseases. PROS2P is a member of the SCL/TAL1 gene family, which is known for its role in the development and regulation of immune responses, as well as cell signaling pathways.

The SCL/TAL1 gene family is composed of four genes: SCL/TAL1, SCL/TAL2, SCL/TAL3, and SCL/TAL4. These genes encode a variety of proteins, including the protein of interest, PROS2P. PROS2P is a 21-kDa protein that is expressed in various tissues and cells, including blood cells, tissues, and organs.

PROS2P is involved in the regulation of cellular processes that are critical for normal immune function, including inflammation, stress responses, and cell signaling pathways. It is also involved in the regulation of cellular processes that are important for the development and progression of various diseases, including cancer.

One of the key functions of PROS2P is its role in the regulation of apoptosis, which is the process by which cells respond to environmental stimuli and attempt to eliminate themselves to prevent injury or disease. PROS2P is involved in the regulation of apoptosis by promoting the expression of genes that promote cell survival and by inhibiting the expression of genes that promote cell death.

In addition to its role in apoptosis, PROS2P is also involved in the regulation of inflammation and stress responses. It is part of the TAL1 signaling pathway, which is involved in the regulation of cellular processes that are critical for immune responses and inflammation. PROS2P is involved in the regulation of the activity of the transcription factor TAL1, which is responsible for promoting the expression of genes that are involved in inflammation and stress responses.

PROS2P is also involved in the regulation of cell signaling pathways that are important for the development and progression of various diseases, including cancer. It is part of the SCL/TAL1 gene family, which is known for its role in the regulation of cellular processes that are critical for cancer development. PROS2P is involved in the regulation of the activity of the transcription factor NF-kappa-B, which is a key regulator of cancer cell signaling pathways.

In conclusion, PROS2P is a gene that has been identified as a potential drug target or biomarker for various diseases. Its role in the regulation of apoptosis, inflammation, and stress responses, as well as its involvement in the regulation of cell signaling pathways that are important for cancer development, make PROS2P an attractive target for further research and development. Further studies are needed to determine the full range of functions of PROS2P and its potential as a drug or biomarker.

Protein Name: Protein S (beta) Pseudogene

The "PROS2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PROS2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets